Angiomotin expression promotes hemangioendothelioma invasion

Oncogene

Volumn 23, Issue 7, 2004, Pages 1469-1473

  Levchenko, Tetyana ^a   Bratt, Anders ^a   Arbiser, Jack L ^b   Holmgren, Lars ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Angiomotin; Angiostatin; Motility

Indexed keywords

ANGIOMOTIN; ANGIOSTATIN; COLLAGEN; MATRIGEL; MUTANT PROTEIN; PDZ PROTEIN; PROTEIN; UNCLASSIFIED DRUG; AMOT PROTEIN, HUMAN; CARRIER PROTEIN; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMANGIOENDOTHELIOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; ENDOTHELIUM; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ANIMALIA;

ANIMALS; AORTA; CARRIER PROTEINS; ENDOTHELIUM; HEMANGIOENDOTHELIOMA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 1442332677     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207264     Document Type: Article

References (24)

1. Auerbach R, Lewis R, Shinners B, Kubai L and Akhtar N. (2003). Clin. Chem., 49, 32-40.
2. Ballestrem C, Wehrle-Haller B, Hinz B and Imhof BA. (2000). Mol. Biol. Cell., 11, 2999-3012.
3. Bastaki M, Nelli EE, Dell'Era P, Rusnati M, Molinari-Tosatti MP, Parolini S, Auerbach R, Ruco LP, Possati L and Presta M. (1997). Arterioscler. Thromb. Vasc. Biol., 17, 454-464.
4. Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Meir EG and Holmgren L. (2002). Gene, 298, 69-77.
5. Edwards DR and Murphy G. (1998). Nature, 394, 527-528.
6. Eriksson K, Magnusson P, Dixelius J, Claesson-Welsh L and Cross MJ. (2003). FEBS Lett., 536, 19-24.
7. Hanahan D and Folkman J. (1996). Cell, 86, 353-364.
8. Holmgren L. (1996). Cancer Metast. Rev., 15, 241-245.
9. Kassis J, Lauffenburger DA, Turner T and Wells A. (2001). Semin. Cancer Biol., 11, 105-117.
10. Lawler J. (2002). J. Cell. Mol. Med., 6, 1-12.
11. Levchenko T, Aase K, Troyanovsky B, Bratt A and Holmgren L. (2003). J. Cell Sci., 116, 3803-3810.
12. Liotta LA. (1984). Am. J. Pathol., 117, 339-348.
13. Murphy G and Gavrilovic J. (1999). Curr. Opin. Cell. Biol., 11, 614-621.
14. Nehls V and Drenckhahn D. (1995). Microvasc. Res., 50, 311-322.
15. Nyberg P, Heikkila P, Sorsa T, Luostarinen J, Heljasvaara R, Stenman UH, Pihlajaniemi T and Salo T. (2003). J. Biol. Chem., Jun 20; 278 (25), 22404-22411.
16. Parker KK, Brock AL, Brangwynne C, Mannix RJ, Wang N, Ostuni E, Geisse NA, Adams JC, Whitesides GM and Ingber DE. (2002). FASEB J., 16, 1195-1204.
17. Pepper MS, Montesano R, Mandriota SJ, Orci L and Vassalli JD. (1996). Enzyme Protein, 49, 138-162.
18. Pintucci G, Bikfalvi A, Klein S and Rifkin DB. (1996). Semin. Thromb. Hemost., 22, 517-524.
19. Serini G, Ambrosi D, Giraudo E, Gamba A, Preziosi L and Bussolino F. (2003). EMBO J., 22, 1771-1779.
20. Staff AC. (2001). Scand J. Clin. Lab. Invest., 61, 257-268.
21. Troyanovsky B, Levchenko T, Mansson G, Matvijenko O and Holmgren L. (2001). J. Cell Biol., 152, 1247-1254.
22. Wang N, Ostuni E, Whitesides GM and Ingber DE. (2002). Cell. Motil. Cytoskeleton, 52, 97-106.
23. Woodhouse EC, Chuaqui RF and Liotta LA. (1997). Cancer, 80, 1529-1537.
24. Vouret-Craviari V, Boquet P, Pouyssegur J and Van Obberghen-Schilling E. (1998). Mol. Biol. Cell, 9, 2639-2653.